Drug Profile
Fentanyl sublingual - iX Biopharma
Alternative Names: WafernylTMLatest Information Update: 28 May 2022
Price :
$50
*
At a glance
- Originator iX Biopharma
- Class Amides; Benzene derivatives; General anaesthetics; Opioid analgesics; Piperidines; Small molecules
- Mechanism of Action Opioid mu receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cancer pain
Most Recent Events
- 28 May 2022 No recent reports of development identified for phase-I development in Cancer-pain(In volunteers) in Australia (Sublingual, Wafer)
- 21 Sep 2020 iX Biopharma has patent protection for WaferiX™ delivery technology in Israel
- 21 Sep 2020 iX Biopharma has patent protection for WaferiX™ delivery technology in the United States, Israel, China, Australia, New Zealand, Singapore, Japan, South Korea, India, Malaysia, and Indonesia, countries in the European Union